23 December 2020 : Clinical Research
Safety and Efficacy of Therapeutic Erythrocytapheresis Treatment in Chronic Mountain Sickness Patients in Shigatse, Tibet, China
Mingyuan NiuBCD, Shekhar SinghEF, Ma MiB, Pian BianB, Zhuoga DejiAB, Duoji MimaA, Xiankai LiACEGDOI: 10.12659/MSM.927853
Med Sci Monit 2020; 26:e927853
Table 5 Evaluation of severity of CMS before and after TEA treatment.
| Before TEA | After TEA | P value | |
|---|---|---|---|
| 6 min walking test (m) | 550.4±79.0 | 578.5±83.1 | <0.001 |
| NYHA(n) | <0.05 | ||
| I | 18 | 27 | |
| II | 13 | 5 | |
| III | 1 | 0 | |
| IV | 0 | 0 | |
| Borg dyspnea scale | 0.88±0.81 | 0.48±0.73 | <0.001 |
| Qinghai CMS score | 7.58±2.31 | 0.45±0.85 | <0.001 |